Urea metabolism in chronic renal failure
- PMID: 4825230
- PMCID: PMC302627
- DOI: 10.1172/JCI107687
Urea metabolism in chronic renal failure
Abstract
Urea degradation was measured during 16 experiments in 13 chronic uremic patients being treated with essential amino acids or their analogues. [(14)C]Urea was injected i.v. and the clearance of labeled urea from its volume of distribution was compared with the simultaneous renal clearance of ordinary urea, which averaged 2.0 liters/day. The difference, extrarenal clearance of urea, averaged 3.1 liters/day as compared with a previously reported mean of 18 liters/day in normal subjects. Thus urea-splitting activity in the gut of uremic subjects expressed in these terms is far less than in normal individuals. Nevertheless, the amount of ammonia N formed from urea in these patients, 3.5 g/day, is not significantly different from normal, owing to their elevated plasma urea. In the same subjects, urea appearance rate was measured as the sum of urea excretion and the daily change in the urea pool. No negative correlation was noted between urea appearance and urea degradation, as might be expected if portal ammonia were being utilized for protein synthesis. However, urea production was positively correlated (r = 0.76) with urea degradation, suggesting that most of the resulting portal ammonia is converted back to urea. The results fail to support the view that degradation of urea in the gut promotes N conservation in uremic subjects maintained on low protein diets.
Similar articles
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
Effects of oral neomycin and kanamycin in chronic uremic patients: I. Urea metabolism.Kidney Int. 1977 Feb;11(2):116-22. doi: 10.1038/ki.1977.16. Kidney Int. 1977. PMID: 846062
-
Evaluation of protein intake by dietary diaries and urea-N excretion in children with chronic renal failure. European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood.Clin Nephrol. 1993 Oct;40(4):208-15. Clin Nephrol. 1993. PMID: 8261677 Clinical Trial.
-
Splanchnic circulation and metabolism in patients with acute liver failure.Dan Med Bull. 2002 Aug;49(3):177-93. Dan Med Bull. 2002. PMID: 12238280 Review.
-
Benzoate-induced changes in glycine and urea metabolism in patients with chronic renal failure.J Pharmacol Exp Ther. 1982 Sep;222(3):572-5. J Pharmacol Exp Ther. 1982. PMID: 7108765
Cited by
-
Acacia gum supplementation of a low-protein diet in children with end-stage renal disease.Pediatr Nephrol. 2004 Oct;19(10):1156-9. doi: 10.1007/s00467-004-1562-5. Epub 2004 Aug 4. Pediatr Nephrol. 2004. PMID: 15293039
-
Effects of Low-Protein, and Supplemented Very Low-Protein Diets, on Muscle Protein Turnover in Patients With CKD.Kidney Int Rep. 2018 Jan 11;3(3):701-710. doi: 10.1016/j.ekir.2018.01.003. eCollection 2018 May. Kidney Int Rep. 2018. PMID: 29854979 Free PMC article.
-
Mechanism of urea nitrogen binding by proposed oxidized starch gastrointestinal absorbents.Experientia. 1975 Sep 15;31(9):1065-6. doi: 10.1007/BF02326962. Experientia. 1975. PMID: 170124
-
Use Of Quantitative Modelling To Elucidate The Roles Of The Liver, Gut, Kidney, And Muscle In Ammonia Homeostasis And How Lactulose And Rifaximin Alter This Homeostasis.Int J Gen Med. 2019 Oct 14;12:367-380. doi: 10.2147/IJGM.S218405. eCollection 2019. Int J Gen Med. 2019. PMID: 31686894 Free PMC article. Review.
-
Six-year dialysis freedom in end-stage renal disease.Clin Exp Nephrol. 2009 Oct;13(5):494-500. doi: 10.1007/s10157-009-0181-7. Epub 2009 May 30. Clin Exp Nephrol. 2009. PMID: 19479191
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources